Medicine’s Ian Neeland shares future predictions for weight-loss drug demand

Scientists are studying weight-loss drugs for way more than weight loss

Time MagazineIan Neeland, associate professor at the School of Medicine, predicted that new weight-loss drugs Wegovy and Zepbound are in high demand—and the clamoring will only increase in coming years due to the potential they can be used for a wide range of other conditions.